Conventional HF Management – Is There a Problem, and Whose Problem Is It?
By
CCM® Therapy
FEATURING
William Abraham
By
CCM® Therapy
FEATURING
William Abraham
This session from HFSA 2022 will explain what Cardiac Contractility Modulation therapy is, how it works, and the expected outcomes when utilizing this treatment for HF in NYHA Class III patients who remain symptomatic despite guideline directed medical therapy.
Dr. William Abraham discusses the challenges that continue to exist in the treatment of heart failure and the unmet needs the provider community must face together.
Login to view comments.
Click here to Login
